News

Jim Cramer Says Trump Administration Should Intervene in Johnson & Johnson (JNJ) Legal Issues – ‘Where Are Capitalist Instincts Here?’
Adam Parker, Trivariate Research CEO, said in a recent interview with CNBC that it’s “hard” to be bullish in this market ...
TODAY on MSN4h
Jim Cramer talks 20 years of ‘Mad Money,’ economic uncertainty
CNBC’s Jim Cramer joins TODAY to celebrate 20 years of “Mad Money” and shares advice for navigating economic uncertainty, ...
Top 10 Stocks to Watch as Investors Brace for Recession
Despite some optimism in the market after President Donald Trump’s indication of possible talks with China, Wall Street ...
What Happened After Jim Cramer Talked About These 13 Stocks
During a recent episode of Mad Money, Jim Cramer offered his perspective on the day’s market rally as he delved into the impact of the ongoing dynamic between President Donald Trump and Federal ...
STAT3dOpinion
NIH cuts will set back research into the rare disease that has terrorized my family
Jim Higgins has an inherited cancer syndrome that has killed his father, sister, and two daughters. He fears NIH cuts will ...
Jim Cramer credits this week's rally to earnings and restraint from the White House
CNBC's Jim Cramer analyzed recent market action, owing gains to strong earnings and the White House's backtrack on its rebuke ...
Jim Cramer Explains Why He Was ‘Willing to Risk My Neck’ on Uber (UBER)
We recently published a list of 10 Stocks on Analysts’ Radar Amid Tariff Turbulence. In this article, we are going to take a ...
Bristol Myers posts better-than-expected quarterly revenue on strong cancer drug sales
(Reuters) -Bristol Myers Squibb reported better-than-expected first-quarter revenue on Thursday and raised its full-year ...
Jim Cramer Warns on Pfizer (PFE): “That 7.7% Yield Is Not a Sign of Strength – It’s a Sign of Weakness”
We recently published a list of Jim Cramer’s Thoughts on These 5 Stocks. In this article, we are going to take a look at ...